Dental pain can have a significant impact on patients. Depending on its severity, toothache can make it difficult for patients to eat, speak, and sleep. In these cases, patients frequently contact their dental practice, seeking care to reduce their pain as soon as possible. Even though clinicians endeavour to see patients as soon as possible when they are in pain, a same day appointment may be unrealistic – potentially requiring patients to wait hours or even days to be seen.

When toothache strikes, act quickly. Recommend Orajel™ to patients with toothache for fast and effective relief[i] whilst they wait for treatment. Unlike traditional pain killers, such as oral analgesics which can take up to an hour to take effect, Orajel™ provides rapid relief.i

Rapid response

Orajel™ is formulated with benzocaine,[ii] a powerful local anaesthetic, which is clinically proven to relieve pain in 2 minutes or less.i This means that patients can expect rapid relief from acute toothache. This is incredibly important to patients, with research suggesting that 63% of patients prioritise speed in pain relief.[iii]

Targeted relief

Orajel™ gives patients the power to apply the gel directly at the source of pain. This kind of precision can really make a difference. A topical gel, Orajel™ delivers localised relief,ii ensuring effective management where it’s needed the most.

Trusted tolerance

Orajel™ is effective and, importantly, safe. 87% of patients experience significant pain relief when they use Orajel™ Extra Strength.i It has a non-systemic formulation and minimal drug interactions.ii This means it is well tolerated,i and a reliable choice for a broad range of patients. It also means that it can be used alongside systemic analgesics, for enhanced pain management.i

How benzocaine works

Benzocaine is absorbed rapidly through the oral mucosa,ii allowing it to act quickly to target dental pain directly, ensuring effective pain management in less than two minutes.i It reversibly binds to and inhibits sodium channels in nerve cell membranes, blocking the conduction of nerve impulses, reducing pain signal transmission.ii [iv] [v]

Multiple options

Additionally, depending on the intensity and the cause of dental pain, clinicians can recommend the most appropriate option from the Orajel™ range. This includes:

Orajel™ Dental Gel

For rapid relief when it’s needed most, recommend Orajel™ Dental Gel.ii It contains 10% w/w benzocaine,ii ideal for reducing pain associated with a broken tooth or in a tooth that may require a filling. The topical gel puts patients in control over the product, enabling them to apply it right to the source of pain, providing targeted relief.ii [vi]

Orajel™ Extra Strength

For relief of severe dental pain, Orajel™ Extra Strength[vii] contains the maximum level of benzocaine available without prescription in the Orajel™ range – 20% w/w benzocaine. The Orajel™ Extra Strength can be applied directly to the painful area, for effective and targeted relief.[viii] The powerful local anaesthetic that works by temporarily blocking the pathway of pain signals along the nerves.iv v vii This numbs the area.

Orajel™ Mouth Gel

For patients with painful mouth ulcers, or denture pain, Orajel™ Mouth Gelviii is an effective option. It provides pain relief at the source of mouth pain, giving patients control over the product for targeted relief. Orajel™ Mouth Gel contains 10% w/w benzocaine, effective for targeted relief.viii

To help patients get their dental pain under control quickly, be sure to recommend Orajel™, for the rapid relief of pain whilst they wait for treatment. Even though reducing the symptoms is not a permanent solution to a patient’s clinical issues, reducing pain and distress whilst they wait for an appointment is vital, and will improve patients’ overall experience when it comes to dental treatment.

 

For essential information, and to see the full range of Orajel products, please visit https://www.orajelhcp.co.uk/

 

[i] Hersh, EV, et al. An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothache. J Am Dent Assoc. 2013;144(5):517–526.

[ii] Orajel Dental Gel. Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1230/smpc

[iii] Orajel Consumer and HCP insights. https://www.orajelhcp.co.uk/

[iv] Khair-ul-Bariyah, S, et al. Benzocaine: review on a drug with unfold potential. Mini-Reviews in Med Chem. 2020;20:3–11.

[v] Singh, R, et al.  Benzocaine. StatPearls. [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. 2024 Mar 20.

[vi] Lee, H-S. Recent advances in topical anesthesia. J Dent Anesth Pain Med. 2016;16(4):237–244.

[vii] Orajel Extra Strength. Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1231/smpc

[viii] Orajel Mouth Gel. Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1229/smpc

Our publications

Discover our range of publications and stay updated on UK dentistry.

Learn more about our magazines
  • Smile OHM cover November December 2024
  • The Probe Issue July 2024
  • BDNJ Issue winter 2020